Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Peutz-Jeghers Syndrome 1 Pancreatitis, Chronic 1 Pancreatic Neoplasms 1 Pancreatic Cyst 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Hip Fractures 1 Glioma 1 Glioblastoma 1 Fractures, Spontaneous 1 Financial Stress 1 Dysplastic Nevus Syndrome 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 COVID-19 1 Breast Neoplasms 1 Brain Neoplasms 1 Bone Neoplasms 1 Ataxia Telangiectasia 1

Interventions

Temozolomide 41 Magnetic Resonance Spectroscopy 19 Radiotherapy 18 Specimen Handling 14 Radiation 12 Bevacizumab 11 Lomustine 9 pembrolizumab 6 fludarabine 5 Surgical Procedures, Operative 5 atezolizumab 4 Nivolumab 4 Ipilimumab 4 Cyclophosphamide 4 Carboplatin 4 Biopsy 4 cemiplimab 3 azeliragon 3 Immunoglobulin G 3 Disulfides 3 Aminolevulinic Acid 3 veliparib 2 trametinib 2 rocakinogene sifuplasmid 2 poly ICLC 2 pamiparib 2 olaparib 2 lutetium Lu 177 dotatate 2 durvalumab 2 dabrafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioblastoma × Data Collection × 90 days × Clear all

NCT07499141 2026-03-30

UFGAG

Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡